IP Library Granted Patent US 7,972,854
Granted Patent B2
US 7,972,854 · App. 10/587,723 · Granted Jul 5, 2011

Methods and compositions for targeted cleavage and recombination

Assignee: Sangamo Biosciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,972,854
App. No.
10/587,723
Granted
Jul 5, 2011
Kind
B2
Abstract

Disclosed herein are methods and compositions for targeted cleavage of a genomic sequence, targeted alteration of a genomic sequence, and targeted recombination between a genomic region and an exogenous polynucleotide homologous to the genomic region.

Claims (24)

1. A method for cleaving cellular chromatin in a region of interest, the method comprising:

(a) selecting the region of interest;

(b) engineering a first zinc finger binding domain to bind to a first nucleotide sequence in the region of interest;

(c) providing a second zinc finger binding domain which binds to a second nucleotide sequence in the region of interest, wherein the second sequence is located between 2 and 50nucleotides from the first sequence;

(d) expressing a first fusion protein in the cell, the first fusion protein comprising the first zinc finger binding domain and a first cleavage half-domain; and

(e) expressing a second fusion protein in the cell, the second fusion protein comprising the second zinc finger binding domain and a second cleavage half domain;

wherein

(i) the first fusion protein binds to the first nucleotide sequence,

(ii) the second fusion protein binds to the second nucleotide sequence,

(iii) said binding of the first and second fusion proteins positions the cleavage half-domains such that the cellular chromatin is cleaved in the region of interest, and

(iv) in at least one of the first or second fusion proteins, the cleavage half-domain is closer to the N-terminus and the zinc finger binding domain is closer to the C-terminus.

2. The method of claim 1 , wherein cleavage occurs between the first and second nucleotide sequences.

3. The method of claim 1 wherein the second zinc finger binding domain is engineered to bind to the second nucleotide sequence.

4. The method of claim 1 wherein the first and second cleavage half-domains are from the same endonuclease.

5. The method of claim 4 wherein the endonuclease is a Type IIS restriction endonuclease.

6. The method of claim 5 wherein the Type IIS restriction endonuclease is Fok I.

7. The method of claim 1 wherein the cellular chromatin is in a chromosome.

8. The method of claim 1 , wherein the first cleavage half domain is from a Type IIS restriction endonuclease.

9. The method of claim 1 , wherein the second cleavage half domain is from a Type IIS restriction endonuclease.

10. The method of claim 1 , wherein the first and second nucleotide sequences are on opposite strands of DNA.

11. The method of claim 10 , wherein, in the first and second fusion proteins, the cleavage half-domains are closer to the N-termini and the zinc finger binding domains are closer to the C-termini.

12. The method of claim 1 , wherein the first and second nucleotide sequences are on the same strand of DNA.

13. The method of claim 12 wherein, in the first fusion protein, the cleavage half-domain is closer to the N-terminus and the zinc finger binding domain is closer to the C-terminus and, in the second fusion protein, the zinc finger binding domain is closer to the N-terminus and the cleavage half-domain is closer to the C-terminus.

14. The method of claim 12 wherein, in the first fusion protein, the zinc finger binding domain is closer to the N-terminus and the cleavage half-domain is closer to the C-terminus and, in the second fusion protein, the cleavage half-domain is closer to the N-terminus and the zinc finger binding domain is closer to the C-terminus.

Assignments (2)
CHANGE OF NAME Recorded May 19, 2017
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 042506/0290 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2007
From: MILLER, JEFFREY C.; ZHANG, LEI
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 019211/0547 →
Continuity (5)
Continuation In Part 10912932 · Aug 6, 2004
Provisional Application 60542780 · Feb 5, 2004
Provisional Application 60556831 · Mar 26, 2004
Provisional Application 60575919 · Jun 1, 2004
Related Publication 20070218528A1 · Sep 20, 2007